Closing the Daily Disposable Gap in Presbyopic Astigmatism
-
February 17, 2026
-
3 min
February 17, 2026
First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL
March 23, 2026
Vizz (aceclidine ophthalmic solution) 1.44%, from Lenz Therapeutics, offers spectacle-free vision and the opportunity to secure patient loyalty.
January 1, 2026
Presbyopia isn’t new—but the way we treat it has changed dramatically. As we continue to embrace these advancements, let’s also commit to the one constant that always makes a difference: a well-trained, well-informed team.
July 8, 2025